# Mikael Lonn

> Mikael Lonn is a Series A investor backing Medical, Life Science and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Total investments: 1
- Last investment: Oct 2024
- Lead investor: 0%
- Last updated: Aug 2026

Mikael Lonn is an Angel Investor.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Thioredoxin Systems | Thioredoxin Systems develops innovative antibiotic regimen for complicated urinary tract infections. | $2.3M | Series A | Oct 30, 2024 |  |

1 of 1 investments shown.

## Co-investors
- [Annexstruktur](https://shizune.co/investors/profile/annexstruktur) — VC Fund, 1 deal together
- [GOBIA Enterprises](https://shizune.co/investors/profile/gobia-enterprises) — VC Fund, 1 deal together
- [GU Ventures](https://shizune.co/investors/profile/gu-holding) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Chalmers Ventures AB](https://shizune.co/investors/profile/chalmers-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

## Featured in investor lists
- [Life Science Angel Investors in Europe](https://shizune.co/investors/life-science-angel-investors-europe)
- [Life Science Angel Investors in Sweden](https://shizune.co/investors/life-science-angel-investors-sweden)
- [Medical Angel Investors in Sweden](https://shizune.co/investors/medical-angel-investors-sweden)
- [Biotechnology Investors in Sweden](https://shizune.co/investors/biotechnology-investors-sweden)
- [Biotech Investors in Sweden](https://shizune.co/investors/biotech-investors-sweden)
- [Biotech Angel Investors in Sweden](https://shizune.co/investors/biotech-angel-investors-sweden)

## FAQ

### What does Mikael Lonn invest in?

Mikael Lonn invests primarily in Medical, Life Science and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Mikael Lonn last invest?

The most recent investment recorded for Mikael Lonn closed in Oct 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co